Overview

Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aims of this prospective, randomized study are: - To assess the effect of clean intermittent catheterization (CIC) - To investigate if MS patients will have symptom reduction (urgency, frequency, nocturia and incontinence) when using CIC in combination with anticholinergic drugs - To identify at what volume of Postvoid Residual (PVR) urine, starting CIC improves bladder control and QoL - To increase the evidence of CIC, and support clinical guidelines of bladder management in MS patients
Phase:
N/A
Details
Lead Sponsor:
Wellspect HealthCare
Treatments:
Cholinergic Antagonists